Pharmacokinetics of the proteasome inhibitor bortezomib (VELCADE™) in male cynomolgus monkeys.

被引：0
|
作者：
Nix, D [1 ]
Milton, M [1 ]
Pligavko, C [1 ]
Nagaraja, N [1 ]
Huang, R [1 ]
Miwa, G [1 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6263S / 6263S
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and tissue distribution of the proteasome inhibitor bortezomib (VELCADE™) in rat and monkey
    Nix, D
    Press, R
    Wehrman, T
    Schenkein, DP
    [J]. BLOOD, 2002, 100 (11) : 224B - 224B
  • [2] Population, pharmacokinetics (PK) of bevacizumab (BV) in cynomolgus monkeys.
    Gaudreault, J
    Siguenza, P
    O'Neill, C
    Torres, E
    Vogel, J
    Hsei, V
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P97 - P97
  • [3] Radiation sensitization of human cervical cancer by proteasome inhibitor Velcade (Bortezomib)
    Kamer, S.
    Ren, Q.
    Sui, Y. P.
    Kari, C.
    Rodeck, U.
    Dicker, A. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S396 - S396
  • [4] Telemetry monitoring of cardiovascular and respiratory function in male cynomolgus monkeys.
    Beck, TW
    Kamenosono, T
    Aïssat, D
    Meyer, S
    Fukuzaki, K
    Nagata, R
    [J]. TOXICOLOGICAL SCIENCES, 2003, 72 : 35 - 35
  • [5] The pharmacokinetics and pharmacodynamics of OPG following single dose administration in cynomolgus monkeys.
    Martin, SW
    Sommers, JS
    Watson, AM
    Young, JD
    Dunstan, CR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S399 - S399
  • [6] Metabolism of the peptide boronic acid proteasome inhibitor bortezomib (VELCADE™) in multiple species
    LaButti, J
    Pekol, T
    Wang, RH
    Hsieh, F
    Daniels, JS
    Nix, D
    Gan, LS
    Miwa, G
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 41 - 41
  • [7] The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer
    Thaler, Sonja
    Thiede, Gitta
    Hengstler, Jan G.
    Schad, Arno
    Schmidt, Marcus
    Sleeman, Jonathan P.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (03) : 686 - 697
  • [8] The effect of proteasome inhibitor with Bortezomib (Velcade™) in B-cell lymphoma cell lines
    Strauss, SJ
    Lui, W
    Schenkein, D
    Shringarpure, R
    Anderson, K
    Lister, TA
    Joel, SP
    [J]. BLOOD, 2003, 102 (11) : 903A - 903A
  • [9] Telemetry in unrestrained cynomolgus glaucomatous monkeys.
    Percicot, CL
    Schnell, C
    Debon, C
    Questel, I
    Faure, E
    Lambrou, GN
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S831 - S831
  • [10] Velcade - Bortezomib for injection - MILLENNIUM - Proteasome Inhibitor approved for treatment of relapsed mantle cell lymphoma
    不详
    [J]. FORMULARY, 2007, 42 (01) : 11 - 12
12345